- https://doi.org/10.1016/j.ctrv.2025.103022
Novel therapies targeting delta-like ligand 3 (DLL3) in pulmonary and gastroenteropancreatic neuroendocrine carcinomas.
Abstract
Translate Article 
Take Notes
Translate Article Take Notes Novel therapies targeting delta-like ligand 3 (DLL3) in pulmonary and gastroenteropancreatic neuroendocrine carcinomas.
More from: Cancer treatment reviewsClinical trials for older cancer patients: A systematic review Genomic distinctions in adolescent and young adult cancer: A comprehensive review. How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers. Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis. Fecal microbiota transplantation to enhance cancer treatment outcomes across different cancer types: A systematic literature review. Checkpoint inhibitor benefit in perioperative gastro-esophageal cancer: A meta-analysis of phase III trials. Combining antibody-drug conjugates with immune checkpoint inhibitors: A new paradigm for breast cancer therapy. Transformation from EGFR-mutant lung adenocarcinoma to small-cell lung cancer: from clonal evolution to lineage reprogramming. Emerging mechanisms of triple-negative breast cancer radioresistance: Interplay between cancer cell mechanisms and the tumor immune microenvironment. Corrigendum to "The importance of education and training in neuroendocrine neoplasms: challenges and opportunities for multidisciplinary management". [Cancer Treat. Rev. 139 (2025) 102998
- New
- Research Article
- 10.1016/j.ctrv.2025.103045
- Nov 1, 2025
- Cancer Treatment Reviews
- New
- Research Article
- 10.1016/j.ctrv.2025.103021
- Nov 1, 2025
- Cancer treatment reviews
- New
- Research Article
- 10.1016/j.ctrv.2025.103003
- Nov 1, 2025
- Cancer treatment reviews
- New
- Research Article
- 10.1016/j.ctrv.2025.103011
- Nov 1, 2025
- Cancer treatment reviews
- New
- Research Article
- 10.1016/j.ctrv.2025.103025
- Nov 1, 2025
- Cancer treatment reviews
- New
- Research Article
- 10.1016/j.ctrv.2025.103002
- Nov 1, 2025
- Cancer treatment reviews
- New
- Research Article
- 10.1016/j.ctrv.2025.103012
- Nov 1, 2025
- Cancer treatment reviews
- New
- Research Article
- 10.1016/j.ctrv.2025.103044
- Nov 1, 2025
- Cancer treatment reviews
- New
- Research Article
- 10.1016/j.ctrv.2025.103026
- Nov 1, 2025
- Cancer treatment reviews
- New
- Addendum
- 10.1016/j.ctrv.2025.103043
- Nov 1, 2025
- Cancer treatment reviews
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.
What is the difference between bacteria and viruses?
What is the function of the immune system?Can diabetes be passed down from one generation to the next?